Supplementary Table S4 from Identification of High-Incidence Populations in the United States for Anti–Epstein-Barr Virus Serologic Screening for Nasopharyngeal Carcinoma
Year: 2024
Type: supplementary-materials
Abstract: Table S4. NPC Mortality Reduction and Cost-Effectiveness among Men for Serology-Based Screening Strategies (Once-Lifetime Screening). Data are reported for a hypothetical cohort of 50-year-old men who develop NPC in low, intermediate, or high-incidence populations under base case assumptions.
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4404933614
